Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
LAS VEGAS, NV / ACCESSWIRE / December 12, 2023 / Odyssey Health, Inc. (OTCOB:ODYY), a company focused on developing unique,...
Month: December 2023
Revolutionizing Healthcare Communication: OnPage Unveils Innovative Slack Integration
OnPage Announces Enhanced Integration With Slack to Empower Healthcare Teams With Unparalleled Critical Alerting and 'Paging' Capabilities Directly From SlackWALTHAM,...
Justera Announces Changes to Management
Toronto, Ontario--(Newsfile Corp. - December 12, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) ("Justera" or the "Company")...
Ainos, Inc. Announces Stock Consolidation
SAN DIEGO, CA / ACCESSWIRE / December 12, 2023 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos," or the "Company"), a diversified...
ASLAN Pharmaceuticals Provides Year-End Update on Its Eblasakimab and Farudodstat Programs
Following the successful TREK-AD Phase 2b study of eblasakimab in moderate-to-severe atopic dermatitis, process is underway to identify potential partners....
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
CAMBRIDGE, MA / ACCESSWIRE / December 12, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced changes to its operating model to...
MEDFINITI Announces Launch of HemWell GEN 2
HemWell MD's second-generation device is ready for release in the U.S., and in Europe, in Q2 2024.TAMPA, FL / ACCESSWIRE...
Protagonist Reports 2-Year Follow Up Data from Rusfertide REVIVE Study at the ASH Annual Meeting Showing Durable Efficacy and No New Safety Signals
Long term follow-up from REVIVE Phase 2 study shows durable hematocrit control, decreased phlebotomy use, long-term tolerability, and no new...
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC
NORTHVALE, NJ / ACCESSWIRE / December 12, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical...
VA Cincinnati Healthcare Implements Palarum SmartSock Technology to Prevent Patient Falls
Cincinnati VA Medical Center Implementing Palarum Smart Sock Technology to Prevent Patient Falls and Reduce Fall-Related CostsCINCINNATI, OH / ACCESSWIRE...
Genmab to Hold 2023 R&D Update and ASH Data Review Meeting
Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 12, 2023 –...
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
Company to review BXCL502 and other potential emerging pipeline candidates Dr. Jeffrey Cummings to discuss agitation relief in Alzheimer’s disease and...
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
WATERTOWN, Mass., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug...
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
Signifies the Successful Fulfillment of BIVIGAM’s Post Marketing Commitments as Part of the Original BLA Approval Expanded Label in the...
Psyched Wellness’s Calm, First Legal Amanita Muscaria Extract, Arrives at Pop-up Grocer in NYC
Toronto, Ontario--(Newsfile Corp. - December 12, 2023) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Alomone Labs Collaborates With Bioz to Strengthen Research Capabilities Through the Innovative Integration of Scientific Citations
PALO ALTO, CA / ACCESSWIRE / December 12, 2023 / Bioz, Inc., a pioneering AI software company dedicated to advancing...
BioNxt Receives Delivery of Premium Commercial Coating and Cutting Equipment for Commercial Manufacturing of Drug Delivery Products
VANCOUVER, BC / ACCESSWIRE / December 12, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
RETRANSMISSION: Defence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2023) - Defence Therapeutics Inc. (CSE: DTC) (OTC Pink: DTCFF) (FSE: DTC) ("Defence"...
IRLAB is Granted Additional Patent for Drug Candidate Pirepemat that Expands its Patent Protection
GOTHENBURG, SE / ACCESSWIRE / December 12, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 12, 2023 - IRLAB...
MedTech Innovator Crowns Medipixel Top 2023 Innovator in Grand Finals Competition of Asia Pacific Accelerator
Transformative healthtech AI company awarded prestigious US$ 175,000 Grand Prize at the 5th annual grand finals hosted by MedTech Innovator...